Dr Michael Bauer on Quantro’s mission to drug the “undruggab...
Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss the company's progress.
Bioconvergence & future human health, with Shai Melcer
Shai Melcer discusses bioconvergence, a multidisciplinary research and development approach that merges technologies.
NICE backs Sobi's Tryngolza for rare disease FCS
Patients in England and Wales with familial chylomicronaemia syndrome will soon have a new treatment option, as NICE backs Sobi's Tryngolza.
Bayer names Christoph Koenen as its new CMO
Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
3rd Annual Personalized Cancer Vaccine Summit 2026 | Decembe...
The 3rd Annual Personalized Cancer Vaccine Summit brings together leaders from across companies to share data-driven insights
CPHI Milan 2026 showcases new Sustainability Summit
The first-time event will bring delegates together to discuss sustainability challenges
Pharmaceutical thought leaders gather at CPHI Milan 2026
Industry leaders will address topics such as manufacturing transformation and future therapies
5th Sustainability in Life Sciences Summit
Join the global sustainability community this November in Boston
CPHI Milan Leadership Summit returns for 2026
Senior pharma leaders will tackle resilience, policy, and industry transformation at CPHI Milan